Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Mid-range Performer
901.2500 2.40 (0.27%)
NSE Dec 30, 2025 15:31 PM
Volume: 43,940
 

logo
Alivus Life Sciences Ltd.
27 Jan 2023
901.25
0.27%
buy
by BOB Capital Markets Ltd.
Target: 585
BOB Capital Markets Ltd.
Q3 revenue up 6% QoQ to Rs 5.4bn supported by sequential recovery in API business to parent and PLI benefits
 
Number of FII/FPI investors decreased from 101 to 92 in Sep 2025 qtr
More from Alivus Life Sciences Ltd.
Recommended
Market closes flat as gains in metal & auto stocks offset losses in other sectors
Trendlyne Marketwatch | 30 Dec 2025, 04:11PM
IPO activity is high on listings, but low on subscriptions
| 29 Dec 2025, 05:02PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021